Europe PCR for Respiratory Infection Diagnostics Market to Grow at a CAGR of 10.1% to reach US$ 2,432.46 Mn Million from 2021 to 2028

Europe PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase (RT-PCR), and Others), Product Type (Reagents & Kits, Instruments, and Others), Infection Type (Bacterial Infections, Viral Infections, and Fungal & Other Pathogens), and End User (Hospitals, Physician Clinics, Clinical Laboratories, Academic & Research Institutions, Biotech & Pharma Companies, and Others)

Publication Month : Aug 2021

  • Report Code : TIPRE00023049
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 248
Inquire Before Buy

PRICING

$3000

$1800

The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028.

The growth of the market is attributed to some of the key driving factors, such as increasing burden of chronic respiratory diseases (CRDs) and increasing use of PCR testing for various respiratory infection diagnostics. However, availability of alternative assays is the major factor hindering the market growth.

Chronic respiratory diseases (CRDs) are among the leading causes of morbidity globally due to the heavy consumption of tobacco. For instance, according to the National Health Services, in England, nearly one in five people is affected by a respiratory disease, and respiratory diseases is the third leading cause of deaths. The burden of CRDs is expected to increase in the future due to poor air quality, addiction to smoking, and rise in geriatric population is more prone to COPD and lung cancer. Moreover, programs initiated in the countries to improve treatment and support the people living with respiratory diseases are likely to increase the demand for PCR for the diagnosis of respiratory diseases. This will lead to the market growth during the forecast period. PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals for identifying influenza virus infection that causes respiratory outbreaks. Therefore, various companies are offering PCR kits that can detect the presence of pathogens that cause respiratory diseases. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the future.

The European economy is seriously hit due to the exponential growth of COVID-19 cases in the region. The rising occurrence rate of coronavirus results in increased stress on the region's healthcare system, which is also rising the demand for diagnostic tests in its healthcare system, supporting the expansion of the sector in this region. Several manufacturers are developing advanced PCR test kits and systems for the detection of COVID-19 virus. As the coronavirus increases, millions of people will need testing. Thus, high throughput molecular testing is expected to play a central role in the future management of the COVID-19 pandemic. Therefore, the need for early detection of respiratory infection diseases is thought to be propelling the European PCR for respiratory infection diagnostics market growth during the forecast period.
PCR for respiratory infection diagnostics market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

EUROPE PCR FOR RESPIRATORY INFECTION DIAGNOSTICS MARKET SEGMENTATION

By Type

  • Real-Time PCR (qPCR)
  • Multiplex PCR
  • Traditional PCR
  • Digital PCR
  • Reverse-Transcriptase (RT-PCR)
  • Others

By Product Type

  • Reagents and Kits
  • Instruments
  • Others

By Infection Type

  • Bacterial Infections
    • Bordetella
    • Streptococcus Pneumoniae
    • Staphylococcus Aureus
    • Haemophilus Influenzae
    • Moraxella Catarrhalis
    • Mycoplasma Pneumoniae
    • Chlamydophila Pneumoniae
    • Legionella
    • Others
  • Viral Infections
    • Rhinoviruses
    • Influenza Virus
    • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
    • Respiratory Syncytial Virus (RSV)
    • Adenovirus
    • Enterovirus
    • Parainfluenza
    • Human Metapneumovirus (hMPV)
    • Others
  • Fungal and Other Pathogens

By End User

  • Hospitals
  • Physician Clinics
  • Clinical Laboratories
  • Academic and Research Institutions
  • Biotech and Pharma Companies
  • Others

By Country

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Norway
  • Rest of Europe

Company Profiles

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD
  • Hologic, Inc.
  • BD
  • BIO-RAD LABORATORIES INC.
  • bioMerieux SA
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Seegene Inc
  •  AusDiagnostics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Product Type, Infection Type, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

  1. Abbott
  2. F. HOFFMANN-LA ROCHE LTD
  3. Hologic, Inc.
  4. BD
  5. BIO-RAD LABORATORIES INC.
  6. bioMerieux SA
  7. QIAGEN
  8. Thermo Fisher Scientific Inc.
  9. Seegene Inc
  10. AusDiagnostics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe PCR for Respiratory Infection Diagnostics Market